Skip to main content
XENE logo

Xenon Pharmaceuticals Inc.

XENENASDAQHealthcareBiotechnology

$34.33Today:- (-)1Y −18.59%

As of Oct 15, 2026 close

Market cap
$3.42B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$33.52$72.66
Volume (live)
-
Avg. volume (3M)
2.28M

Xenon Pharmaceuticals Inc. (XENE) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Xenon Pharmaceuticals Inc. stock.

Analyst Consensus Rating

Investment consensus from 17 professional research analysts

Consensus Rating

Buy
Based on 17 unique analysts
(18 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$70.00
+103.90% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest XENE Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Unknown Analyst
Guggenheim
BuyInitiates
$73.00
Brian Abrahams
RBC Capital
BuyMaintains
$70.00
David Martin PhD
Bloom Burton
BuyMaintains
$74.00 → $71.00
Tessa Romero
JP Morgan
BuyReiterates
$82.00
Paul Matteis
Stifel Nicolaus
BuyMaintains
-
Laura Chico
Wedbush
BuyMaintains
$71.00 → $55.00
Douglas Tsao
HC Wainwright
BuyMaintains
$74.00
Myles Minter
William Blair
BuyMaintains
-
David Hoang
Deutsche Bank
HoldUpgrades
$90.00 → $46.00
Joseph Thome
TD Cowen
BuyMaintains
-
Paul Choi
Goldman Sachs
BuyMaintains
$75.00
Jason Gerberry
BofA Securities
BuyMaintains
-
Benjamin Burnett
Wells Fargo
BuyReiterates
$69.00 → $64.00
Brian Skorney
Baird
BuyMaintains
$97.00 → $90.00
Serge Belanger
Needham
BuyMaintains
$78.00 → $60.00
Paul Choi
Goldman Sachs
BuyMaintains
$75.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Cory Kasimov
Evercore ISI Group
BuyMaintains
$80.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 5, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for XENE?

The analyst consensus rating for XENE is Buy, based on the latest ratings from 17 analysts over the last 90 days.

What is the average price target for XENE?

The average 12-month price target for XENE is $70.00, representing an upside of 103.9% from the Oct 15, 2026 close of $34.33.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.